Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4216 AL 4230

Rho GTPases as therapeutic targets in Alzheimer's disease

Aguilar BJ, Zhu Y, Lu Q.

Alzheimers Res Ther. 2017 Dec 15;9(1):97. doi: 10.1186/s13195-017-0320-4.

Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease

Sahoo AK, Dandapat J, Dash UC, Kanhar S.

J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14.

Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats

Dhull DK, Kumar A.

Inflammopharmacology. 2018 Aug;26(4):925-938. doi: 10.1007/s10787-017-0431-3. Epub 2017 Dec 16.

Cinnamon, a promising prospect towards Alzheimer's disease

Momtaz S, Hassani S, Khan F, Ziaee M, Abdollahi M.

Pharmacol Res. 2018 Apr;130:241-258. doi: 10.1016/j.phrs.2017.12.011. Epub 2017 Dec 16.

Targeting Neuroinflammation to Treat Alzheimer's Disease

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, Hoeijmakers L, Hoffmann A, Iaccarino L, Jahnert S, Kuhbandner K, Landreth G, Lonnemann N, Löschmann PA, McManus RM, Paulus A, Reemst K, Sanchez-Caro JM, Tiberi A, Van der Perren A, Vautheny A, Venegas C, Webers A, Weydt P, Wijasa TS, Xiang X, Yang Y.

CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3.

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, Heales SJR, Walker MC, Williams RSB.

Lancet Neurol. 2018 Jan;17(1):84-93. doi: 10.1016/S1474-4422(17)30408-8. Epub 2017 Dec 16.

Nasal steroids as a possible treatment for Alzheimer's disease

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152.

Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease

Kumar K, Kumar A, Keegan RM, Deshmukh R.

Biomed Pharmacother. 2018 Feb;98:297-307. doi: 10.1016/j.biopha.2017.12.053. Epub 2017 Dec 27.

Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease

Caraci F, Nicoletti F, Copani A.

Curr Opin Pharmacol. 2018 Feb;38:1-7. doi: 10.1016/j.coph.2017.12.001. Epub 2017 Dec 23.

An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer's disease

Marcelli S, Ficulle E, Piccolo L, Corbo M, Feligioni M.

Pharmacol Res. 2018 Apr;130:420-437. doi: 10.1016/j.phrs.2017.12.023. Epub 2017 Dec 26.

Drug discovery, development and delivery in Alzheimer's disease

Brambilla D.

Pharm Res. 2017 Dec 29;35(1):3. doi: 10.1007/s11095-017-2329-6.

A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease

Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R.

Bioorg Med Chem. 2018 Feb 1;26(3):543-550. doi: 10.1016/j.bmc.2017.12.042. Epub 2017 Dec 26.

P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease

Sita G, Hrelia P, Tarozzi A, Morroni F.

Oxid Med Cell Longev. 2017;2017:7905486. doi: 10.1155/2017/7905486. Epub 2017 Nov 26.

Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules

Umar T, Hoda N.

Curr Top Med Chem. 2017;17(31):3370-3389. doi: 10.2174/1568026618666180112161024.

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

Rampa A, Gobbi S, Concetta Di Martino RM, Belluti F, Bisi A.

Curr Top Med Chem. 2017;17(31):3361-3369. doi: 10.2174/1568026618666180112161406.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias